Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of homoharringtonine in treating patients who have
chronic phase chronic myelogenous leukemia. Drugs used in chemotherapy, such as
homoharringtonine, work in different ways to stop cancer cells from dividing so they stop
growing or die